Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections

Author： Finney Michael S. Crank Christopher W. Segreti John

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.12, 2005-12, pp. : 1923-1926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus

By Antony Suresh

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 4, 2006-04 ,pp. : 293-295

Informa Healthcare

Access to resources Recommend Favorite

Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram‐Positive Infections

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 935-948

John Wiley & Sons Inc

Access to resources Recommend Favorite

Shortened hospital stay for childhood bone and joint infections: Analysis of 265 prospectively collected culture-positive cases in 1983–2005

By Pääkkönen Markus Kallio Markku J. T. Kallio Pentti E. Peltola Heikki

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 9, 2012-09 ,pp. : 683-688

Informa Healthcare

Access to resources Recommend Favorite

Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer

By Bharali Dhruba J Yalcin Murat Davis Paul J Mousa Shaker A

Nanomedicine, Vol. 8, Iss. 12, 2013-12 ,pp. : 1943-1954

Future Medicine

Access to resources Recommend Favorite

Drug-resistant tuberculous meningitis

By Garg Ravindra K Jain Amita Malhotra Hardeep S Agrawal Avinash Garg Rajiv

Expert Review of Anti-Infective Therapy, Vol. 11, Iss. 6, 2013-06 ,pp. : 605-621

Informa Healthcare

Access to resources Recommend Favorite